Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSTAMATINIB vs FULVESTRANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSTAMATINIB vs FULVESTRANT: Safety Overview

Metric FOSTAMATINIB FULVESTRANT
Total FAERS Reports 6,394 17,675
Deaths Reported 453 3,087
Death Rate 7.1% 17.5%
Hospitalizations 1,493 4,103
Average Patient Age 64.7 yrs 63.0 yrs
% Female Patients 60.8% 99.0%
FDA Approval Date Apr 17, 2018 Apr 25, 2002
Manufacturer Rigel Pharmaceuticals, Inc. BluePoint Laboratories
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription